Palatin Technologies, Inc. (PTN)
NASDAQ: PTN · Real-Time Price · USD
6.49
-0.93 (-12.53%)
At close: Oct 15, 2026, 4:00 PM EDT
6.90
+0.41 (6.32%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of $11.92 million as of October 15, 2026. Its market cap has increased by 67.84% in one year.
Market Cap
11.92M
Enterprise Value
4.65M
1-Year Change
67.84%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 1, 1998, Palatin Technologies's market cap has decreased from $18.60M to $11.92M, a decrease of -35.93%. That is a compound annual growth rate of -1.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 13.20M | -49.62% |
| Dec 31, 2025 | 26.20M | 20.74% |
| Dec 31, 2024 | 21.70M | -60.33% |
| Dec 29, 2023 | 54.70M | 106.42% |
| Dec 30, 2022 | 26.50M | -77.62% |
| Dec 31, 2021 | 118.40M | -23.81% |
| Dec 31, 2020 | 155.40M | -13.28% |
| Dec 31, 2019 | 179.20M | 24.53% |
| Dec 31, 2018 | 143.90M | -11.99% |
| Dec 29, 2017 | 163.50M | 199.45% |
| Dec 30, 2016 | 54.60M | 20.80% |
| Dec 31, 2015 | 45.20M | 56.94% |
| Dec 31, 2014 | 28.80M | - |
| Dec 31, 2013 | 28.80M | 23.08% |
| Dec 31, 2012 | 23.40M | 67.14% |
| Dec 30, 2011 | 14.00M | -12.50% |
| Dec 31, 2010 | 16.00M | -54.93% |
| Dec 31, 2009 | 35.50M | 355.13% |
| Dec 31, 2008 | 7.80M | -54.12% |
| Dec 31, 2007 | 17.00M | -88.28% |
| Dec 29, 2006 | 145.10M | -24.27% |
| Dec 30, 2005 | 191.60M | 33.43% |
| Dec 31, 2004 | 143.60M | 28.56% |
| Dec 31, 2003 | 111.70M | 197.87% |
| Dec 31, 2002 | 37.50M | -20.21% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 14.56M |
| Estrella Immunopharma | 14.13M |
| Tvardi Therapeutics | 14.01M |
| BioCardia | 13.92M |
| Pasithea Therapeutics | 13.80M |
| Cerenome | 13.77M |
| Lipocine | 13.60M |
| Allarity Therapeutics | 13.49M |